NovaBay Pharmaceuticals, Inc. — DEF 14A Filings
26 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by NovaBay Pharmaceuticals, Inc. (NBY), sorted by most recent first. Each row links to the full filing on EdgarLookup. NovaBay Pharmaceuticals, Inc. has filed 26 DEF 14A documents with the SEC since 2010. To view all SEC filings by NovaBay Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
3
3/A
4
4/A
424B3
424B4
424B5
5
5/A
8-A12B
8-K
8-K/A
ARS
CERTAMX
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFM14A
EFFECT
FWP
NT 10-K
POS AM
POS EX
PRE 14A
PREM14A
PRER14A
REGDEX
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | FORM DEF 14A | 0001437749-26-003571 | Feb 10, 2026 | Mar 12, 2026 |
| DEF 14A | DEF 14A | 0001829126-25-007608 | Sep 23, 2025 | Oct 16, 2025 |
| DEF 14A | FORM DEF 14A | 0001437749-25-008439 | Mar 19, 2025 | Apr 16, 2025 |
| DEF 14A | FORM DEF 14A | 0001437749-24-012384 | Apr 18, 2024 | May 28, 2024 |
| DEF 14A | FORM DEF 14A | 0001437749-23-015017 | May 18, 2023 | — |
| DEF 14A | FORM DEF 14A | 0001437749-22-023306 | Sep 30, 2022 | Nov 10, 2022 |
| DEF 14A | FORM DEF 14A | 0001437749-22-007683 | Mar 30, 2022 | May 11, 2022 |
| DEF 14A | FORM DEF 14A | 0001437749-21-026317 | Nov 12, 2021 | Dec 17, 2021 |
| DEF 14A | FORM DEF 14A | 0001437749-21-008478 | Apr 7, 2021 | May 21, 2021 |
| DEF 14A | FORM DEF 14A | 0001437749-20-007773 | Apr 15, 2020 | May 26, 2020 |
| DEF 14A | FORM DEF 14A | 0001437749-19-018344 | Sep 13, 2019 | Oct 9, 2019 |
| DEF 14A | FORM DEF 14A | 0001437749-19-007618 | Apr 19, 2019 | May 30, 2019 |
| DEF 14A | FORM DEF 14A | 0001437749-18-007058 | Apr 18, 2018 | May 31, 2018 |
| DEF 14A | FORM DEF 14A | 0001437749-17-020184 | Dec 5, 2017 | Dec 20, 2017 |
| DEF 14A | FORM DEF 14A | 0001437749-17-006921 | Apr 21, 2017 | Jun 2, 2017 |
| DEF 14A | FORM DEF 14A | 0001437749-16-029615 | Apr 18, 2016 | May 3, 2016 |
| DEF 14A | FORM DEF 14A | 0001437749-15-021284 | Nov 20, 2015 | Dec 11, 2015 |
| DEF 14A | FORM DEF 14A | 0001437749-15-016891 | Sep 4, 2015 | Sep 30, 2015 |
| DEF 14A | FORM DEF 14A | 0001437749-15-008471 | Apr 30, 2015 | Jun 12, 2015 |
| DEF 14A | FORM DEF 14A | 0001437749-14-007226 | Apr 25, 2014 | May 30, 2014 |
| DEF 14A | DEFINITIVE SCHEDULE 14A | 0001437749-13-004662 | Apr 24, 2013 | Jun 11, 2013 |
| DEF 14A | SCHEDULE 14A | 0001437749-12-004189 | Apr 26, 2012 | Jun 12, 2012 |
| DEF 14A | SCHEDULE 14A INFORMATION | 0001437749-11-002529 | Apr 25, 2011 | Jun 9, 2011 |
| DEF 14A | DEF 14A | 0001437749-10-001193 | Apr 22, 2010 | Jun 16, 2010 |
| DEF 14A | NOVABAY PHARMACEUTICALS DEF 14A 6-4-2009 | 0001140361-09-009727 | Apr 16, 2009 | Jun 4, 2009 |
| DEF 14A | DEFINITIVE NOTICE AND PROXY STATEMENT | 0001193125-08-088111 | Apr 23, 2008 | Jun 5, 2008 |